
Oncology NEWS International
- Oncology NEWS International Vol 9 No 7
- Volume 9
- Issue 7
President Names New NCAB Chair, Three New Members
WASHINGTON-President Clinton has named Phillip A. Sharp, PhD, of the Massachusetts Institute of Technology, to serve as chair of the National Cancer Advisory Board (NCAB). Dr. Sharp succeeds J. Michael Bishop, MD, of the University of California, San Francisco. The President has also named three new board members-James O. Armitage, MD, James Harold French, Jr., MD, and Arthur Wesley Nienhuis, MD. The 18-member board advises the President, the Secretary of Health and Human Services, and the director of the National Cancer Institute on the policies and activities of the NCI.
WASHINGTONPresident Clinton has named Phillip A. Sharp, PhD, of the Massachusetts Institute of Technology, to serve as chair of the National Cancer Advisory Board (NCAB). Dr. Sharp succeeds J. Michael Bishop, MD, of the University of California, San Francisco. The President has also named three new board membersJames O. Armitage, MD, James Harold French, Jr., MD, and Arthur Wesley Nienhuis, MD. The 18-member board advises the President, the Secretary of Health and Human Services, and the director of the National Cancer Institute on the policies and activities of the NCI.
Dr. Armitage is dean of the College of Medicine, University of Nebraska, Omaha. Dr. French is clinical assistant professor of plastic surgery, Georgetown University. Dr. Nienhuis, director, St. Jude Childrens Hospital, was reappointed to the board. He was first named a member in December 1998 to fill a vacant seat.
Articles in this issue
almost 26 years ago
Couric Urges Doctors to Talk to Patients About Colon Canceralmost 26 years ago
Automated Imaging Notification System Close to Fail-Safealmost 26 years ago
Higher Dairy Consumption Linked to Prostate Cancer Riskalmost 26 years ago
First-Year Funding of Early Detection Research Network Completealmost 26 years ago
Gritty Antitobacco Ads and More From Legacy Foundationalmost 26 years ago
Tositumomab Effective for Low-Grade Follicular Lymphomaalmost 26 years ago
New Awards Spotlight Courage of Cancer Survivorsalmost 26 years ago
Hospital Volume Shown to Predict Breast Cancer Outcomealmost 26 years ago
New Drug Information Websitealmost 26 years ago
NCCN Presents Updated Colorectal Cancer GuidelinesNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Related Content



















































